A phase II study of weekly irinotecan as first-line therapy for patients with metastatic pancreatic cancer

  • Hideki Ueno
  • , Takuji Okusaka
  • , Akihiro Funakoshi
  • , Hiroshi Ishii
  • , Kenji Yamao
  • , Osamu Ishikawa
  • , Shinichi Ohkawa
  • , Soh Saitoh

Research output: Contribution to journal › Article › peer-review

46 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of weekly irinotecan as first-line therapy for patients with metastatic pancreatic cancer'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science